Abstract
Pseudomonas aeruginosa is an opportunistic pathogen strongly related to difficult-to-treat nosocomial infections with a high mortality rate. The bacterium's mutagenic phenomena confer the ability to acquire resistance to different groups of antimicrobial agents and this portrays a challenging scenario in the fight against infections caused by this agent. In this scenario, there is a need …